NCT06921902

Glycemic Metrics and Patterns in People With and Without Prediabetes

Observation and Identification of Glycemic Metrics and Patterns in People With and Without Prediabetes (PREMAP)

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 2,000 (estimated)
• Sponsor: Abbott Diabetes Care · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.

Detailed description

This is a non-pivotal, non-randomized, multi-center, prospective, non-significant risk to evaluate the glycemic profiles of people with and without a prediabetes diagnosis using continuous glucose monitoring. Up to 2000 subjects will be enrolled in up to 20 sites. Approximately 50% of evaluable subjects will have a prediabetes diagnosis.

Conditions

• Pre Diabetes

Interventions

Type	Name	Description
DEVICE	FreeStyle Libre 3	Abbott Sensor Based Glucose Monitoring System (FreeStyle Libre 3 System)

Timeline

• Start date: 2025-02-28
• Primary completion: 2026-12-01
• Completion: 2026-12-01
• First posted: 2025-04-10
• Last updated: 2026-04-09

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study